Collagenase Clostridium Histolyticum for Refractory Iatrogenic Esophageal Strictures
Status:
Unknown status
Trial end date:
2020-12-30
Target enrollment:
Participant gender:
Summary
In this open-label pilot study we want to investigate whether intralaesional injection with
collagenase clostridium histolyticum (XiapexR) into the esophageal stricture followed by
dilation 24 hours later improves the outcome of patients with refractory esophageal
anastomotic strictures as compared to dilation alone (standard of care).